Obesity Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with Polycystic Ovary Syndrome (PCOS) based on specific criteria: irregular periods (cycles shorter than 21 days or longer than 35 days) and higher-than-normal male hormone levels, confirmed by blood tests.
- People who are classified as obese, meaning their weight is at or above the 95th percentile for their age group.
- Females between the ages of 12 and 18, who have had their period for at least 2 years.
- People whose PCOS symptoms and obesity have continued despite making lifestyle changes (such as diet and exercise) for at least 4 months.
- People who are in good overall health aside from the conditions listed above.
Who may not be able to join:
- People whose thyroid function blood tests came back abnormal at the screening visit.
- People with known or suspected diabetes, high fasting blood sugar, or abnormal results on a blood sugar marker test called HbA1c.
- People with a specific hormonal condition called non-classic congenital adrenal hyperplasia.
- People with a condition called hyperprolactinemia, which involves having too much of a hormone called prolactin in the blood.
- People with a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma), a related genetic condition called MEN2, or a history of pancreas inflammation (pancreatitis).
- People who have been taking certain medications — including metformin, GLP-1 medications, the contraceptive pill, progesterone, or other insulin-sensitising medicines — for 6 weeks or more before the screening visit.
- People who are currently pregnant or who have been pregnant at any point.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 1 + 904-408-7895
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in LH pulse frequency after 4 months of GLP-1 agonist use.; Change in average levels of LH and FSH after 4 months of GLP-1 agonist use.; Change in average levels of Total testosterone and Estradiol after 4 months of GLP-1 agonist use.; Change in average levels of progesterone after 4 months of GLP-1 agonist use.; Change in LH amplitude.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.